Ocugen, Inc.·4

Jan 5, 4:06 PM ET

Musunuri Shankar 4

4 · Ocugen, Inc. · Filed Jan 5, 2023

Insider Transaction Report

Form 4
Period: 2023-01-03
Musunuri Shankar
DirectorChief Executive Officer
Transactions
  • Award

    Option (Right to Buy)

    2023-01-03+1,771,6541,771,654 total
    Exercise: $1.25Exp: 2033-01-03Common Stock (1,771,654 underlying)
  • Award

    Common Stock

    2023-01-03+1,475,4102,227,950 total
Holdings
  • Common Stock

    (indirect: By LLC)
    1,145,299
Footnotes (3)
  • [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Ocugen Inc.'s (the "Company's") common stock. The RSUs vest annually in three equal installments commencing on January 3, 2024, subject to continued service with the Company on the applicable vesting dates. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock.
  • [F2]The Reporting Person is a member and officer of KVM Holdings, LLC and has voting and investment power over the shares held by KVM Holdings, LLC.
  • [F3]The option vests annually in equal installments over three years commencing on January 3, 2024, subject to continued service with the Company on the applicable vesting dates.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES